Viewing Study NCT04211103


Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2025-12-31 @ 3:46 AM
Study NCT ID: NCT04211103
Status: UNKNOWN
Last Update Posted: 2021-08-27
First Post: 2019-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab in Pre Neoplastic High Grade HPV-related Vulvar and Cervical Lesions
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2773
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View